GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer.
Möbus V, Lück HJ, Ladda E, Klare P, Engels K, Schmidt M, Schneeweiss A, Grischke EM, Wachsmann G, Forstbauer H, Untch M, Marmé F, Blohmer JU, Jackisch C, Huober J, Stickeler E, Reinisch M, Link T, Sinn B, Janni W, Denkert C, Seiler S, Solbach C, Schmatloch S, Rey J, Loibl S.
Möbus V, et al. Among authors: seiler s.
NPJ Breast Cancer. 2024 Jul 30;10(1):66. doi: 10.1038/s41523-024-00675-x.
NPJ Breast Cancer. 2024.
PMID: 39080281
Free PMC article.